This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
September 2026 quarter: consolidated revenue up 15% and profit down 59% year on year
SHK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.5 pts less than Nifty Microcap 250 and 1.2 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated quarter ended 30 September 2026 versus the year-ago quarter: revenue from operations Rs 636.19 crore versus Rs 553.72 crore; profit Rs 14.56 crore versus Rs 35.17 crore. Margin before interest, depreciation and tax fell from 19.3% to 8.6% of revenue. Standalone profit was Rs 1.65 crore. A company owned by promoters bought a subsidiary for Rs 0.46 crore. Six-month consolidated operating cash flow was negative Rs 42.87 crore.
Profit fell despite revenue growth; weak margins and negative cash flow may pressure sentiment. The small related party sale needs watching.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹636.2 Cr | ₹553.9 Cr | +14.9% |
| Operating profit | ₹23.78 Cr | ₹11.38 Cr | +109.0% |
| Profit after tax | ₹14.56 Cr | ₹9.17 Cr | +58.8% |
| EBITDA margin | 12.4% | 9.6% | +2.8 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.